Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs
NATCO's Pharmacovigilance Department was inspected from October 30, 2023 to November 1, 2023
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
The inspection was conducted at its Goa, Vema manufacturing facility
The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
Subscribe To Our Newsletter & Stay Updated
